APPLIED SCIENCE, INC.

Applied Science, Inc. develops regulated medical devices and SaaS platforms serving blood collection and chronic care management markets. The company operates two primary business lines: HemoFlow, an automated whole blood collection system for blood banks, and AdaptivMD, a remote patient monitoring and chronic care management platform. HemoFlow provides mixers, software services, and consumables to optimize transfusion medicine workflows, enabling automated paperless collection, error and waste reduction, enhanced phlebotomist productivity, and centralized device management across blood collection facilities. The platform processes approximately 18 million whole blood donations annually, supporting 54 million transfused blood products globally, with 99.74% customer retention over 13 years. AdaptivMD serves community and rural healthcare providers with value-based care solutions, incorporating remote patient monitoring, telehealth, diabetic retinopathy screening, painless blood glucose monitoring, chronic care management, and EHR-integrated workflows to improve health equity for underserved populations. The company has delivered regulated devices and SaaS services for over 15 years to private and public blood banks worldwide. Applied Science emphasizes interoperability, seamless integrations, and automation efficiencies across its platform portfolio. Service capabilities include passionate, experienced, and agile customer support.